» Articles » PMID: 32272228

TRPV4 Calcium Influx Controls Sclerostin Protein Loss Independent of Purinergic Calcium Oscillations

Overview
Journal Bone
Date 2020 Apr 10
PMID 32272228
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Skeletal remodeling is driven in part by the osteocyte's ability to respond to its mechanical environment by regulating the abundance of sclerostin, a negative regulator of bone mass. We have recently shown that the osteocyte responds to fluid shear stress via the microtubule network-dependent activation of NADPH oxidase 2 (NOX2)-generated reactive oxygen species and subsequent opening of TRPV4 cation channels, leading to calcium influx, activation of CaMKII, and rapid sclerostin protein downregulation. In addition to the initial calcium influx, purinergic receptor signaling and calcium oscillations occur in response to mechanical load and prior to rapid sclerostin protein loss. However, the independent contributions of TRPV4-mediated calcium influx and purinergic calcium oscillations to the rapid sclerostin protein downregulation remain unclear. Here, we showed that NOX2 and TRPV4-dependent calcium influx is required for calcium oscillations, and that TRPV4 activation is both necessary and sufficient for sclerostin degradation. In contrast, calcium oscillations are neither necessary nor sufficient to acutely decrease sclerostin protein abundance. However, blocking oscillations with apyrase prevented fluid shear stress induced changes in osterix (Sp7), osteoprotegerin (Tnfrsf11b), and sclerostin (Sost) gene expression. In total, these data provide key mechanistic insights into the way bone cells translate mechanical cues to target a key effector of bone formation, sclerostin.

Citing Articles

Osteocyte-mediated mechanical response controls osteoblast differentiation and function.

Buck H, Stains J Front Physiol. 2024; 15:1364694.

PMID: 38529481 PMC: 10961341. DOI: 10.3389/fphys.2024.1364694.


The Multifaceted Functions of TRPV4 and Calcium Oscillations in Tissue Repair.

Jiang D, Guo R, Dai R, Knoedler S, Tao J, Machens H Int J Mol Sci. 2024; 25(2).

PMID: 38256251 PMC: 10816018. DOI: 10.3390/ijms25021179.


TRPV4 differentially controls inflammatory cytokine networks during static and dynamic compression of the intervertebral disc.

Easson G, Savadipour A, Gonzalez C, Guilak F, Tang S JOR Spine. 2023; 6(4):e1282.

PMID: 38156056 PMC: 10751971. DOI: 10.1002/jsp2.1282.


Spectrum of PHEX Mutations and FGF23 Profiles in a Taiwanese Cohort With X-Linked Hypophosphatemia Including 102 Patients.

Su P, Yu J, Wu Y, Tsai Y, Lo F, Lin J In Vivo. 2023; 38(1):341-350.

PMID: 38148081 PMC: 10756449. DOI: 10.21873/invivo.13444.


Osteoblast-lineage calcium/calmodulin-dependent kinase 2 delta and gamma regulates bone mass and quality.

Leser J, Torre O, Gould N, Guo Q, Buck H, Kodama J Proc Natl Acad Sci U S A. 2023; 120(47):e2304492120.

PMID: 37976259 PMC: 10666124. DOI: 10.1073/pnas.2304492120.


References
1.
Papanicolaou S, Phipps R, Fyhrie D, Genetos D . Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells. Biorheology. 2009; 46(5):389-99. DOI: 10.3233/BIR-2009-0550. View

2.
Agrawal A, Gartland A . P2X7 receptors: role in bone cell formation and function. J Mol Endocrinol. 2015; 54(2):R75-88. DOI: 10.1530/JME-14-0226. View

3.
Spatz J, Wein M, Gooi J, Qu Y, Garr J, Liu S . The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro. J Biol Chem. 2015; 290(27):16744-58. PMC: 4505423. DOI: 10.1074/jbc.M114.628313. View

4.
Lenertz L, Baughman C, Waldschmidt N, Thaler R, van Wijnen A . Control of bone development by P2X and P2Y receptors expressed in mesenchymal and hematopoietic cells. Gene. 2015; 570(1):1-7. PMC: 5268819. DOI: 10.1016/j.gene.2015.06.031. View

5.
Schaffler M, Cheung W, Majeska R, Kennedy O . Osteocytes: master orchestrators of bone. Calcif Tissue Int. 2013; 94(1):5-24. PMC: 3947191. DOI: 10.1007/s00223-013-9790-y. View